Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
PLX-4720 treatment at 30 mg/kg/day significant inhibits the tumor growth of 8505c xenografts by >90%
Binding studies indicate that it has no effect on monoamine uptake and no affinity for α
2010 Sep 22
dark and at 0-4oC for short term (days to weeks) or -20oC for long term (months to years)
Bedaquiline Catalog No.:M8161-2 PLX-4720 treatment at 30 mg/kg/dayBedaquiline, also known as TMC207 and R207910, is a diarylquinoline anti tuberculosis drug, which was discovered by a team led by Koen Andries at Janssen Pharmaceutica. Bedaquiline blocks the proton pump for ATP synthase of mycobacteria. ATP production is required for cellular energy production and its loss leads to cell death, even in dormant or nonreplicating mycobacteria. It is the first member of a new class of drugs called the diarylquinolines.
US$ 208.50
US$ 161.00
US$ 147.00